About D3R

AN OPEN RESOURCE TO ADVANCE COMPUTER-AIDED DRUG DESIGN

The Drug Design Data Resource (D3R) aims to advance the technology of computer-aided drug discovery through the interchange of high quality protein-ligand datasets and workflows, and by holding community-wide, blinded prediction challenges. The D3R project is based at the University of California San Diego (UCSD), where it is co-directed by Drs. Rommie Amaro and Michael Gilson. An additional D3R component, focused on determining, validating and archiving protein-ligand co-crystal structures, is hosted at Rutgers the State University of New Jersey and led by Dr. Stephen K. Burley, who is Director of the RCSB Protein Data Bank.

Advisory Board

• Aled Edwards, Structural Genomics Consortium
• Charles Grimshaw, Takeda Pharmaceutical Company Limited
  
• David Mobley, Department of Pharmaceutical Sciences, University California, Irvine
  
• John Moult, Institute of Bioscience and Biotechnology research, University of Maryland
  
• Adrian Roitberg, Department of Chemistry, University of Florida
• Torsten Schwede, Biozentrum, University of Basel
• Martin Stahl, Roche